All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @midlifeinvintage on Instagram · 147s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @midlifeinvintage's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Hi my loves. I don't know whether this is a Perry Menopause thing or just a state of the fucking world thing.
  2. 0:10But I can't get over this feeling of intense vulnerability and fragility.
  3. 0:20I honestly just feel like weeping all the time at the moment.
  4. 0:26I feel lost and uneasy and directionless.
  5. 0:32And as someone who's struggling with their mental health and then neurodivergence and everything else,
  6. 0:37I'm very self-aware.
  7. 0:39But this particular feeling, and I can't really put my finger on it to describe it, is brand new.
  8. 0:46It's making it quite hard to find the joy in life.
  9. 0:51The reason I'm talking about this is because I've encountered such a lot of people recently
  10. 0:57who are feeling the same way.
  11. 1:00And I don't necessarily think that there's some sort of mental health crisis among us,
  12. 1:07although there probably is.
  13. 1:09But there is a huge societal crisis.
  14. 1:13And we are trying to go about our lives laboring with this undercurrent of misery and horror.
  15. 1:22And for some reason, I do not feel as resilient to things as I felt in the past.
  16. 1:31My emotions are rollercoaster.
  17. 1:33My anxiety is getting hard to control.
  18. 1:37I just have this general feeling of ennui and malaise and hopelessness.
  19. 1:45And while I realise this is not cheerful or inspiring, I just want to say that anyone else feeling this way,
  20. 1:52I am with you 100%.
  21. 1:55I hope you've all got some support like I have because the world is not an easy place to navigate right now.
  22. 2:04I think if you're also dealing with the onslaught of your hormones betraying you,
  23. 2:10things just seem extra extra extra extra extra extra difficult.
  24. 2:15I'm just sending you love and putting out there that it's okay not to be okay.
  25. 2:22But I hope we're all a bit more okay soon.

@midlifeinvintage's mental health message, fact-checked

Lori-Jade Siegel

Instagram creator

46.1K viewsView on Instagram

Quick answer

The creator describes symptoms consistent with perimenopausal mood dysregulation, including emotional lability, heightened anxiety, and anhedonia, in the context of existing neurodivergence and mental health challenges. Fluctuating estradiol during the menopausal transition is a well-documented driver of these symptoms through its effects on serotonergic and GABAergic pathways. Evaluation by a clinician familiar with both hormone physiology and psychiatric comorbidities would be appropriate given the complexity she describes.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 11 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @midlifeinvintage's mental health message, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@midlifeinvintage's mental health message, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@midlifeinvintage's mental health message, fact-checked" from Lori-Jade Siegel. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator describes symptoms consistent with perimenopausal mood dysregulation, including emotional lability, heightened anxiety, and anhedonia, in the context of existing neurodivergence and mental health challenges.

The reason this review is not generic is the source wording and the canonical claim label "trt it s ok not to be ok that s it that s my point lov." In this clip, the useful excerpt is: "Hi my loves." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Freeman et al.
People who land here are usually trying to understand whether the Testosterone claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator describes symptoms consistent with perimenopausal mood dysregulation, including emotional lability, heightened anxiety, and anhedonia, in the context of existing neurodivergence and mental health challenges.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator describes symptoms consistent with perimenopausal mood dysregulation, including emotional lability, heightened anxiety, and anhedonia, in the context of existing neurodivergence and mental health challenges. Fluctuating estradiol during the menopausal transition is a well-documented driver of these symptoms through its effects on serotonergic and GABAergic pathways. Evaluation by a clinician familiar with both hormone physiology and psychiatric comorbidities would be appropriate given the complexity she describes.
  • Bromberger and Kravitz (2011) found perimenopause is a distinct vulnerability window for depressive symptoms, even in women with no prior psychiatric history.
  • Freeman et al. (2006, Archives of General Psychiatry) documented a 2-4x increased risk of major depressive episodes during the menopausal transition compared to premenopausal women.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Bromberger and Kravitz (2011) found perimenopause is a distinct vulnerability window for depressive symptoms, even in women with no prior psychiatric history.
  • Freeman et al. (2006, Archives of General Psychiatry) documented a 2-4x increased risk of major depressive episodes during the menopausal transition compared to premenopausal women.
  • Estrogen fluctuation disrupts serotonin and GABA pathways, producing mood instability and anxiety that does not always meet formal diagnostic thresholds but is still clinically significant.
  • Women with ADHD or other neurodivergent profiles may experience amplified perimenopausal symptoms because estrogen supports dopamine function, per Agnew-Blais et al. (2023, Psychological Medicine).
  • Transdermal estradiol has RCT-level evidence for improving perimenopausal mood symptoms, per Soares et al. (2001, Archives of General Psychiatry), and is a distinct clinical conversation from antidepressant therapy.
  • Testosterone deficiency in women is associated with fatigue, low mood, and reduced resilience during perimenopause, though prescribing practices remain inconsistent with the available evidence.
  • Attributing all perimenopausal mood symptoms to external stress rather than hormonal physiology risks leaving a treatable biological condition unaddressed.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @midlifeinvintage actually say?

She described feeling "intense vulnerability and fragility," like weeping constantly, and struggling with "rollercoaster" emotions and anxiety that's getting "hard to control." She framed this as possibly perimenopause-related, possibly a broader societal crisis, and landed on a simple message: it's okay not to be okay. She also noted that people dealing with hormone changes seem to find everything "extra extra extra extra difficult."

Worth saying upfront: this video isn't making medical claims. It's a creator sharing her emotional state and reaching out to others who feel the same. The fact-check question here isn't whether she's lying. It's whether the science supports the connection she's drawing between hormonal shifts and this kind of psychological free-fall.

Does the science back this up?

Yes, more than most people realize. The perimenopause-to-mental-health link is not just anecdote. It's one of the better-documented phenomena in women's midlife health, and it's been consistently underdiagnosed for decades.

A landmark study by Bromberger and Kravitz (2011, Psychiatric Clinics of North America) found that the perimenopause transition significantly increases risk for depressive symptoms, even in women with no prior history of depression. The hormonal volatility during this window, particularly fluctuating estradiol levels, appears to sensitize certain brain circuits involved in mood regulation. Freeman et al. (2006, Archives of General Psychiatry) identified that women in the menopausal transition were two to four times more likely to develop a major depressive episode than premenopausal women.

The anxiety piece also holds up. Estrogen has modulatory effects on serotonin and GABA systems. When estrogen drops erratically, those systems destabilize. The result can look a lot like what she's describing: not a clean diagnosis, but a persistent background hum of dread and emotional instability. Gordon et al. (2018, JAMA Internal Medicine) showed sleep disruption during perimenopause compounds these mood effects significantly.

What did they get wrong (or right)?

She got the core thing right. The feeling she describes, that specific blend of vulnerability, malaise, and lost resilience, tracks closely with what the clinical literature calls perimenopausal mood dysregulation. It's not depression in the classic sense for every woman, but it's not nothing either.

Where she's appropriately uncertain, she says so. She admits she can't "put her finger on it" and explicitly questions whether this is perimenopause or the state of the world. That epistemic humility is actually more honest than a lot of wellness content that confidently attributes everything to hormones.

One thing worth flagging: she mentions neurodivergence alongside hormonal changes without drawing a connection, but the research suggests that connection is real. ADHD symptoms, for example, are frequently reported to worsen during perimenopause, partly because estrogen supports dopamine function (Agnew-Blais et al., 2023, Psychological Medicine). That's a conversation she didn't have, probably because she doesn't know the data exists. Neither do most clinicians.

She does not make any specific treatment claims, which keeps this video on the right side of the line. She recommends having support. That's it. Hard to argue with that.

What should you actually know?

If you recognize yourself in what she's describing, the first thing to know is that "I feel like weeping all the time" in perimenopause is not just a mindset problem. There is a biological mechanism behind it. That matters because it affects what might actually help.

Hormone therapy, specifically estradiol, has evidence as a treatment for perimenopausal depression and mood instability. A randomized controlled trial by Soares et al. (2001, Archives of General Psychiatry) showed transdermal estradiol outperformed placebo for depressive symptoms in perimenopausal women. This is not the same as treating clinical major depression in postmenopausal women, and the evidence base is different. Context matters.

Standard antidepressants are sometimes prescribed for these symptoms. They can help, but they're not always the right tool if the primary driver is hormonal volatility rather than a serotonin deficit. Getting a clinician who understands both is not a small ask but it's the ask worth making.

Testosterone also plays a role that often gets ignored. Low testosterone in women is associated with fatigue, low mood, and reduced resilience. It's not a cure-all, but for some women in perimenopause it's part of the picture. The evidence is growing, though prescribing practices lag significantly behind the research.

The broader societal framing she offers, that there's a collective undercurrent of misery affecting everyone's baseline resilience, isn't wrong. But it shouldn't be used as a reason to dismiss individual symptoms that have a treatable hormonal component. Both things can be true simultaneously.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Lori-Jade Siegel · Instagram creator

46.1K views on this video

IT’S OK NOT TO BE OK.⁣ ⁣ That’s it. That’s my point. ⁣ ⁣ Love to you ⁣ ⁣ 🫶🏻

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about bromberger?

Bromberger and Kravitz (2011) found perimenopause is a distinct vulnerability window for depressive symptoms, even in women with no prior psychiatric history.

What does the video say about freeman et al. (2006, archives of general psychiatry) documented a?

Freeman et al. (2006, Archives of General Psychiatry) documented a 2-4x increased risk of major depressive episodes during the menopausal transition compared to premenopausal women.

What does the video say about estrogen fluctuation disrupts serotonin?

Estrogen fluctuation disrupts serotonin and GABA pathways, producing mood instability and anxiety that does not always meet formal diagnostic thresholds but is still clinically significant.

What does the video say about women with adhd?

Women with ADHD or other neurodivergent profiles may experience amplified perimenopausal symptoms because estrogen supports dopamine function, per Agnew-Blais et al. (2023, Psychological Medicine).

What does the video say about transdermal estradiol has rct-level evidence for improving perimenopausal mood symptoms,?

Transdermal estradiol has RCT-level evidence for improving perimenopausal mood symptoms, per Soares et al. (2001, Archives of General Psychiatry), and is a distinct clinical conversation from antidepressant therapy.

What does the video say about testosterone deficiency in women?

Testosterone deficiency in women is associated with fatigue, low mood, and reduced resilience during perimenopause, though prescribing practices remain inconsistent with the available evidence.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Lori-Jade Siegel, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.